Loading...
Loading...
Application UK00916189201 · Registered

| Application Number | UK00916189201 |
| Status | Registered |
| Owner | H. Lundbeck A/S |
| Filed | 2016-12-21 |
| Registered | 2017-04-25 |
| Renewal Due | 2026-12-21 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Yes. T ACCESS is currently a registered UK trademark, with renewal due on 2026-12-21. It is protected under UK intellectual property law and can be enforced against infringing uses.
Colour Claimed : Blue-green; Orange.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceuticals and medical preparations and substances; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes; pharmaceuticals for treatment of cognitive disorders and diseases.
Education; providing of training; arranging and conducting seminars, conferences, symposiums, workshops (training) and courses; educational and training services in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and training services in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention provided electronically, on-line, via cable or Internet or other electronic media; arranging and conducting of expert forums, including on-line, in the form of seminars, conferences, symposia, workshops (education) and courses; on-line training programs; providing on-line publications (not down-loadable), including of books, reports, brochures, booklets, leaflets, including patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention.
Scientific and technological services and research and design relating thereto; industrial analysis and research services; providing software and access to data and information in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; arranging and conducting of expert forums, including on-line, in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; pharmaceutical research and development; scientific and technological services and research in the field of disorders, diseases and prevention; scientific and technological services and research in the field of the central nervous system, brain disorders and central nervous system related disorders, diseases and pharmaceuticals; medical research, trials and tests; clinical research, trials and tests; diagnostic research and tests, including clinical trials; providing for medical and medicinal information in the field of research and development, science, clinical tests and trials.
Medical, clinical, therapeutic and healthcare services; medical, therapeutic and healthcare information services; services in the field of psychiatry and psychology and central nervous system diseases and disorders; advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing for medical and medicinal information in the field of diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical data and analyses designed to provide patients and clients customized information, including regarding medical dose, diagnosis, therapeutic issues and medical management.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
'T ACCESS' is a registered trademark on the UK IPO register, owned by H. Lundbeck A/S. The application (UK00916189201) was filed on 21 December 2016 and registered on 25 April 2017. The registration is set to expire on 21 December 2026.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 41 (education, entertainment & sporting services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services), specifically covering: Colour Claimed : Blue-green; Orange.
The trademark is represented by Stobbs.
UK trademark UK00916189201 for the mark 'T ACCESS' in Class 5, 41, 42, 44 is recorded on the UK IPO register as owned by H. Lundbeck A/S. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00916189201 for the mark 'T ACCESS' as registered.
UK trademark UK00916189201 for the mark 'T ACCESS' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 41 (education, entertainment & sporting services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceuticals and medical preparations and substances; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system;…
UK trademark UK00916189201 for the mark 'T ACCESS' was filed at the UK IPO on 21 December 2016 and registered on 25 April 2017.
UK trademark UK00916189201 for the mark 'T ACCESS' is currently recorded as valid until 21 December 2026, at which point it will need to be renewed with the UK IPO to remain in force.
Stobbs is listed as the attorney / representative of record for UK trademark UK00916189201 for the mark 'T ACCESS' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.